Haematology & Oncology

Sickle Cell Disease

An inherited haemoglobinopathy in which deoxygenated haemoglobin S polymerises, making red cells rigid and adhesive; vaso-occlusion causes ischaemic pain while haemolysis causes chronic anaemia and progressive organ damage.

Definition

Sickle cell disease is a group of inherited beta-globin disorders in which haemoglobin S, alone or paired with another abnormal beta-globin variant, causes chronic haemolysis, vaso-occlusion and progressive organ damage. Sickle cell trait, one HbS gene alongside one normal gene, is not sickle cell disease.

First principles

HbS polymerisation ties tissue injury to oxygen tension

Sickle cell disease is caused by inherited beta-globin variants that produce haemoglobin S (HbS). When deoxygenated, HbS polymerises into rigid rods that distort the red cell. Repeated sickling damages the membrane and makes the cell adhesive, so hypoxia, dehydration, cold, infection and acidosis all precipitate vaso-occlusion. Fetal haemoglobin (HbF) blocks polymerisation, which is why infants are protected for their first few months, and why raising HbF is therapeutic.

You’ve reached the end of the preview

The rest of this extended textbook page is part of full access. Create a free account to read the sample topics in full and try sample questions, then upgrade to unlock every high-yield and extended page, plus the complete question bank.

This page is exam revision material, not medical advice, and must not be used for patient care. Always check drug doses against the BNF and current guidance. Full disclaimer.